| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.36▼ | 2.35▲ | 2.34▲ | 2.32▲ | 2.15▲ |
| MA10 | 2.36▼ | 2.33▲ | 2.32▲ | 2.31▲ | 2.00▲ |
| MA20 | 2.35▼ | 2.31▲ | 2.32▲ | 2.19▲ | 1.69▲ |
| MA50 | 2.32▲ | 2.30▲ | 2.34▲ | 1.98▲ | 2.74▼ |
| MA100 | 2.31▲ | 2.34▲ | 2.22▲ | 1.67▲ | 4.90▼ |
| MA200 | 2.32▲ | 2.20▲ | 2.12▲ | 2.12▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.008▲ | 0.007▲ | 0.004▲ | 0.197▲ |
| RSI | 53.520▲ | 56.110▲ | 54.400▲ | 58.957▲ | 57.051▲ |
| STOCH | 63.333 | 82.003▲ | 79.645 | 70.566 | 65.184 |
| WILL %R | -71.429 | -23.810▲ | -17.241▲ | -17.264▲ | -22.628▲ |
| CCI | -70.085 | 88.176 | 113.514▲ | 51.462 | 127.431▲ |
| MA | $ACRV Price Crossed Above MA(7) | Set Alert |
|
Thursday, November 13, 2025 01:11 PM
Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancer Preparing for initial clinical data disclosure for ACR-2316 from the Phase 1 trial ...
|
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
|
Monday, October 27, 2025 07:24 PM
Acrivon Therapeutics, Inc. ((ACRV)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/11/25 | 2.30 | 2.37 | 2.25 | 2.36 | 286,911 |
| 25/11/25 | 2.37 | 2.3825 | 2.22 | 2.32 | 379,581 |
| 24/11/25 | 2.31 | 2.39 | 2.2907 | 2.36 | 271,075 |
| 21/11/25 | 2.30 | 2.36 | 2.18 | 2.30 | 226,387 |
| 20/11/25 | 2.38 | 2.481 | 2.20 | 2.26 | 833,011 |
| 19/11/25 | 2.40 | 2.44 | 2.31 | 2.36 | 291,688 |
| 18/11/25 | 2.38 | 2.48 | 2.3601 | 2.43 | 647,230 |
| 17/11/25 | 2.22 | 2.48 | 2.19 | 2.38 | 1,342,956 |
| 14/11/25 | 2.01 | 2.32 | 2.00 | 2.24 | 1,187,067 |
| 13/11/25 | 2.22 | 2.25 | 2.06 | 2.07 | 398,324 |
|
|
||||
|
|
||||
|
|